Silk Road Medical

Silk Road Medical is one of the...

• Russell 3000.

Silk Road Medical is a company listed under the stock ticker SILK (US).

View the org chart displaying its 24 main executives

Most searched biographies at Silk Road Medical

• Chas Mckhann, Chief Executive Officer
• Tony Chou, Director
• Jack Lasersohn, Director

Popular executive movements at Silk Road Medical

• Chas Mckhann has joined the company as Chief Executive Officer  (posted on November 3 2023).
• Erica Rogers, who is Director, President and Chief Executive Officer will soon leave the company  (posted on October 11 2023).

Create your alert
to follow the executive moves at Silk Road Medical.

Silk Road Medical has 2,285 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Silk Road Medical

• Silk Road Medical Reports Second Quarter 2022 Financial Results - Silk Road Medical, Inc.
• Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022 - Silk Road Medical, Inc.
• Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR - Silk Road Medical, Inc.
• Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients - Silk Road Medical, Inc.
• Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing - Silk Road Medical, Inc.
• Silk Road Medical Reports First Quarter 2022 Financial Results - Silk Road Medical, Inc.
• Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System - Silk Road Medical, Inc.
• Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference - Silk Road Medical, Inc.
• Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022 - Silk Road Medical, Inc.
• Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook - Silk Road Medical, Inc.
• View more press releases Close

Social media about Silk Road Medical

• Silk Road Medical on Wikipedia, Google News & Yahoo Finance
• Silk Road Medical on LinkedIn, Twitter & YouTube

Contact by email its executives including Chas Mckhann

Call Silk Road Medical at +1 408...

View the org chart

Register to receive your alert

Report an error